Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients

Nali, Luiz Henrique da Silva; Moraes, Lenira; Fink, Maria Cristina Domingues; Callegaro, Dagoberto; Romano, Camila Malta; Oliveira, Augusto Cesar Penalva de.
Arq. neuropsiquiatr ; 72(12): 960-965, 02/12/2014. tab, graf
Artigo em Inglês | LILACS | ID: lil-731039

Documentos relacionados

  1. Undetectable JC virus CSF PCR in patients with JC virus-induced progressive multifocal leukoencephalopathy.
  2. Immunology of progressive multifocal leukoencephalopathy.
  3. Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy.
  4. Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody.
  5. Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes.
  6. Revisiting JC virus and progressive multifocal leukoencephalopathy.
  7. Rapid-progressing progressive multifocal leukoencephalopathy in two patients newly diagnosed with HIV: case series and review of literature.
  8. Progressive multifocal leukoencephalopathy on dimethyl fumarate with preserved lymphocyte count but deep T-cells exhaustion.
  9. Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
  10. JC Polyomavirus Modifies the Expression of Human microRNAs in Progressive Multifocal Leukoencephalopathy Brain.